Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

AI precision medicine accelerates the search for rare disease treatment

Posted on September 20th, 2021 by

AI and precision medicine are both changing drug discovery and development as we know it. Precision medicine that is powered by AI stands to be transformative, especially for the treatment of rare diseases. Elsevier was recently part of a collaboration that sought to demonstrate how AI precision medicine could lead researchers to new treatments for brain tumors faster.

(more…)

Accelerating synthetic chemistry with a predictive retrosynthesis solution

Posted on August 12th, 2021 by

In most aspects of life, we think of “endless possibilities” as a good thing. But in science, the wealth of possibilities can be daunting. Pharmaceutical researchers typically start with a disease that they want to tackle, find a target, and then try to identify compounds which interact with that target. There may be around 200-300 drug candidates per project, and synthesis planning and execution usually takes four to eight weeks per drug candidate. This process requires many chemists and a huge, costly effort to proceed.

(more…)

Confronting the Problem of AI Bias

Posted on June 18th, 2021 by

When thinking of artificial intelligence (AI), many people rely on cultural touchstones from science fiction films and TV. They might think of HAL, the calm-voiced AI from 2001: A Space Odyssey, or Data, the even-tempered android from Star Trek. We tend to imagine that artificial intelligence will be driven by reason, logic and facts – not by the emotions and prejudices that get us regular humans into trouble so often.

(more…)

4 Notable Life Sciences Trends from the Tech Trends Report

Posted on June 4th, 2021 by

The Future Today Institute has released its 2021 Tech Trends Report (14th Annual Edition), a comprehensive report on strategic trends that it anticipates will affect business, government, education, media and society in the coming year. We noted four trends discussed in the report’s Health, Medicine & Science section that will be of particular interest to those in the pharmaceutical and life sciences sectors.

(more…)

  1. 1
  2. 2